Molecular modeling approaches for the discovery of adenosine A2B receptor antagonists: current status and future perspectives

被引:16
|
作者
Deb, Pran Kishore [1 ]
Chandrasekaran, Balakumar [1 ]
Mailavaram, Raghuprasad [2 ]
Tekade, Rakesh Kumar [3 ]
Jaber, Abdul Muttaleb Yousef [1 ]
机构
[1] Philadelphia Univ, Philadelphia Univ Jordan, Fac Pharm, POB 1, Amman 19392, Jordan
[2] Sri Vishnu Coll Pharm, Pharmaceut Chem Div, Bhimavaram 534202, Andhra Pradesh, India
[3] NIPER, Opposite Air Force Stn Palaj, Gandhinagar 382355, Gujarat, India
关键词
PROTEIN-COUPLED RECEPTORS; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; BINDING MODES; XANTHINE DERIVATIVES; DYNAMICS SIMULATIONS; MEDICINAL CHEMISTRY; AFFINITY; POTENT; QSAR;
D O I
10.1016/j.drudis.2019.05.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenosine receptors (ARs) are classified as A(1), A(2A),A(2B), and A(3) subtypes belonging to the superfamily of G-protein-coupled receptors (GPCRs). Several molecular modeling approaches have been developed for A(2B)AR and its antagonists, from the construction of a homology model, molecular docking, molecular dynamics (MD) simulations, and 3D quantitative structure-activity relationship (QSAR) modeling to pharmacophore modeling, each of which has different objectives and outcomes. In this review, we provide a systematic outline of advances in molecular modeling approaches towards A(2B)AR for deducing its structure and interactions with various types of antagonist. The information, methods and perspectives presented here provides impetus for medicinal chemists to discover potential ligands that can bind selectively with higher affinity to A(2B)AR.
引用
收藏
页码:1854 / 1864
页数:11
相关论文
共 50 条
  • [41] New pyrrolopyrimidin-6-yl benzenesulfonamides:: Potent A2B adenosine receptor antagonists
    Esteve, Cristina
    Nueda, Arsenio
    Diaz, Jose Luis
    Beleta, Jorge
    Cardenas, Alvaro
    Lozoya, Estrella
    Cadavid, Maria Isabel
    Loza, Maria Isabel
    Ryder, Hamish
    Vidal, Bernat
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (14) : 3642 - 3645
  • [42] PRESENT STATUS AND FUTURE PERSPECTIVES OF MUSCARINIC RECEPTOR ANTAGONISTS
    LONDONG, W
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1986, 21 : 55 - 60
  • [43] Molecular Glue Discovery: Current and Future Approaches
    Dewey, Jeffrey A.
    Delalande, Cleïmence
    Azizi, Saara-Anne
    Lu, Vivian
    Antonopoulos, Dionysios
    Babnigg, Gyorgy
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (14) : 9278 - 9296
  • [44] Endothelin-receptor antagonists: current and future perspectives
    Ray, A
    Hegde, LG
    Chugh, A
    Gupta, JB
    DRUG DISCOVERY TODAY, 2000, 5 (10) : 455 - 464
  • [45] The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma
    Zablocki, J
    Kalla, R
    Perry, T
    Palle, V
    Varkhedkar, V
    Xiao, DM
    Piscopio, A
    Maa, T
    Gimbel, A
    Hao, J
    Chu, N
    Leung, K
    Zeng, DW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) : 609 - 612
  • [46] Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists
    Crespo, Abel
    El Maatougui, Abdelaziz
    Biagini, Pierfrancesco
    Azuaje, Jhonny
    Coelho, Alberto
    Brea, Jose
    Isabel Loza, Maria
    Isabel Cadavid, Maria
    Garcia-Mera, Xerardo
    Gutierrez-de-Teran, Hugo
    Sotelo, Eddy
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (11): : 1031 - 1036
  • [47] The role of the A2B adenosine receptor in pulmonary fibrosis
    Blackburn, Michael
    Pedroza, Mesias
    PURINERGIC SIGNALLING, 2010, 6 : 32 - 32
  • [48] Adenosine receptors and diabetes: Focus on the A2B adenosine receptor subtype
    Merighi, Stefania
    Borea, Pier Andrea
    Gessi, Stefania
    PHARMACOLOGICAL RESEARCH, 2015, 99 : 229 - 236
  • [49] Adenosine (A2b) receptor in bovine corneal endothelium
    Allen, KY
    Sun, XC
    Bonanno, JA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U186 - U186
  • [50] A2B ADENOSINE RECEPTOR IN CONTROL OF INSULIN RESISTANCE
    Johnston-Cox, H.
    Eisenstein, A.
    Koupenova, M.
    Carroll, S.
    Ravid, K.
    CARDIOLOGY, 2013, 125 : 454 - 454